A Janus-faced role of the unfolded protein response in antitumor immunity.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 23762789)

Published in Oncoimmunology on May 01, 2013

Authors

Navin R Mahadevan1, Jeffrey J Rodvold, Maurizio Zanetti

Author Affiliations

1: The Laboratory of Immunology; Department of Medicine and Moores Cancer Center; University of California; San Diego, CA USA.

Articles by these authors

Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. J Immunol (2005) 1.54

Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc Natl Acad Sci U S A (2011) 1.34

Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol (2008) 1.31

CD4 T cells in tumor immunity. Springer Semin Immunopathol (2005) 1.13

Lipocalin 2 in cancer: when good immunity goes bad. Cancer Lett (2011) 1.09

Cutting edge: antigen presentation to CD8 T cells after influenza A virus infection. J Immunol (2009) 1.04

Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One (2010) 1.02

KDEL-retained antigen in B lymphocytes induces a proinflammatory response: a possible role for endoplasmic reticulum stress in adaptive T cell immunity. J Immunol (2008) 1.00

Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. J Immunol (2011) 0.98

Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming. PLoS One (2012) 0.96

CD8 T cell priming by B lymphocytes is CD4 help dependent. Eur J Immunol (2005) 0.95

Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine (2004) 0.93

The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice. J Immunol (2005) 0.93

Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. Proc Natl Acad Sci U S A (2002) 0.92

HIV-specific immunity during structured antiviral drug treatment interruption. Vaccine (2003) 0.91

T cell immunity using transgenic B lymphocytes. Proc Natl Acad Sci U S A (2004) 0.89

Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. Cell Immunol (2010) 0.85

ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner. BMC Cancer (2011) 0.85

Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer. Blood (2005) 0.84

Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Res (2008) 0.84

Immunogenic HLA-B7-restricted peptides of hTRT. Int Immunol (2006) 0.84

TLR9-independent activation of B lymphocytes by bacterial DNA. DNA Cell Biol (2006) 0.84

Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines. Immunology (2006) 0.83

Telomerase immunity from bench to bedside: round one. J Transl Med (2007) 0.82

Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen. Eur J Immunol (2004) 0.82

Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses. Clin Cancer Res (2006) 0.82

Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus. Eur J Immunol (2003) 0.82

Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway. Cancer Lett (2012) 0.81

Synthesis and delivery of short, noncoding RNA by B lymphocytes. Proc Natl Acad Sci U S A (2013) 0.80

Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells. J Immunol (2008) 0.80

Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines. J Inflamm Res (2010) 0.80

CD4 T cell priming in dendritic cell-deficient mice. Int Immunol (2003) 0.80

Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation. Int Rev Immunol (2006) 0.78

Protection of IgE-mediated allergic sensitization by active immunization with IgE loops constrained in GFP protein scaffold. J Immunol Methods (2007) 0.78

Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and participating in the development of anti-inflammatory functional behavior of phagocytic macrophages. Hum Immunol (2003) 0.77

Sensing hyperploidy and immune surveillance: a pas-de-deux. Cell Cycle (2013) 0.75

Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis. J Immune Based Ther Vaccines (2004) 0.75

Plasmid DNA and IL-4 modulate expression of mHC class I and costimulatory molecules in B lymphocytes. DNA Cell Biol (2007) 0.75

Memory T Cells. Preface. Adv Exp Med Biol (2010) 0.75

Identification of immunogenic peptides of the self-tumor antigen: our experience with telomerase reverse transcriptase. Methods Mol Biol (2010) 0.75

Cytotoxic T-cells specific for natural IgE peptides downregulate IgE production. Cell Immunol (2005) 0.75

In utero DNA immunisation. Immunity over tolerance in fetal life. Vaccine (2005) 0.75